Skip to content
by Legal Desire
19 June 2021

Herbert Smith Freehills Advises Sponsors On Carsgen Therapeutics’ HK$3.1 Billion Hong Kong IPO

Advising firms

Deal team

17 lawyers named
LawyerFirmSeniorityPracticeOffice
Matt Emsley Lead Herbert Smith Freehills Kramer Partner Not stated Hong Kong
Stanley Xie Lead Herbert Smith Freehills Kewei Partner Not stated Not stated
Siddhartha Sivaramakrishnan Herbert Smith Freehills Kramer Partner Not stated Singapore
George Wu Herbert Smith Freehills Kramer Of counsel Not stated Not stated
Maisie Ko Herbert Smith Freehills Kramer Senior associate Not stated Not stated
Echo Shen Herbert Smith Freehills Kramer Associate Not stated Not stated
Angela Yuen Herbert Smith Freehills Kramer Associate Not stated Not stated
Hilary Chong Herbert Smith Freehills Kramer Other Not stated Hong Kong
Sean Ji Herbert Smith Freehills Kewei Associate Not stated Not stated
Sunny Li Herbert Smith Freehills Kramer Other Not stated Sydney
Jasmin Tsang Herbert Smith Freehills Kramer Trainee Not stated Hong Kong
Alisha Chan Herbert Smith Freehills Kramer Other Not stated Not stated
Jessica Sun Herbert Smith Freehills Kewei Other Not stated Not stated
Lucy Yao Herbert Smith Freehills Kewei Other Alternative Legal Services Not stated
Helen Liang Herbert Smith Freehills Kewei Other Not stated Not stated
Selina Wang Herbert Smith Freehills Kewei Other Not stated Not stated
Shawna Peng Herbert Smith Freehills Kewei Other Not stated Not stated

14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
HKD 3.10bn (HK$3.1 billion)
What the figure measures
Issue size
Client
Not stated
Counterparties
CARsgen Therapeutics Holdings Limited (Issuer)
Goldman Sachs (Underwriters)
UBS (Underwriters)